Logo

CollabRx

CollabRx, Medytox Reach Merger Agreement

Under the terms of the deal, CollabRx will operate as a wholly owned subsidiary of the combined firm, and its shareholders will own 10 percent of the new company. 

CollabRx, Medytox Negotiating Merger

The firms have inked a non-binding letter of intent to negotiate a merger, and Medytox has provided CollabRx with a loan.

CollabRx, Cartagenia Partner to Provide Comprehensive Solution for Cancer Testing

NEW YORK (GenomeWeb) – CollabRx and Cartagenia have teamed up to provide an end-to-end software solution for clinical laboratories that supports genetic testing and reporting, including next-generation sequencing-based tests, in oncology.

Downloads and Upgrades: TranSmart 1.2, RNAcentral 1.0; CollabRx's GVA, and more
Premium

The TranSmart Foundation has launched version 1.2 of its open-source knowledge management platform for life science research.

OncoSolutions Taps CollabRx to Provide Variant Interpretation Services
Premium

NEW YORK (GenomeWeb) – CollabRx said this week that Singapore-based private oncology firm OncoSolutions Cancer Center has signed a multi-year agreement to use CollabRx's Genetic Variant Annotation (GVA) service to analyze tumor genetic data.
Jun 20, 2014

Downloads and Upgrades: CancerRx, iPathwayGuide, Maverix Analytic Platform, and More
Premium

May 30, 2014

Downloads and Upgrades: CancerRx, CloudDx, and Cytoscape 3.1.1
Premium

May 6, 2014

Affymetrix's Q1 Revenues Rise on CytoScan Adoption, Biobank Opportunities, Ag-bio Growth
Premium

Apr 23, 2014

People in the News: Paul Billings, Stephen Rusckowski
Premium

Apr 22, 2014

Affymetrix, CollabRx Deal Adds Copy Number Interpretation to Clinical Research Labs' Analytical Workflows
Premium

Apr 16, 2014

Affymetrix, CollabRx Partner to Integrate Genomics Analysis Tools

Apr 2, 2014

Jackson Lab to Incorporate CollabRx Informatics in Genetic Cancer Tests

Jan 27, 2014

CollabRx Tapped to Provide Interpretation Resources for CellNetix's Tests

Dec 11, 2013

CollabRx to Provide Cynvenio with Clinical Data Interpretation Services

Dec 6, 2013

Codified Genomics Targets Clinical Testing Labs with Variant Interpretation Pipeline
Premium

Nov 22, 2013

Strand Kicks Off EAP to Test Clinical Variant Interpretation and Reporting Software
Premium

Nov 11, 2013

Quest to Use CollabRx's Genetic Variant Annotation Services in NGS Testing

Aug 23, 2013

CollabRx Partners with Medical News Site to Launch Molecular Oncology Mobile App
Premium

Aug 9, 2013

CollabRx Launches Variant Interpretation Service With Initial Focus on Oncology
Premium

Jun 18, 2013

CollabRx, U. of Chicago Medical Center Collaborate on NGS Data Interpretation

May 8, 2013

CollabRx, GeneInsight Collaborate on Sequencing Data

Apr 9, 2013

CollabRx, Sengenics Partner on Cancer Diagnostics

Apr 4, 2013

CollabRx, OncoDNA Combining Technologies for Cancer Mutation Panels

Mar 8, 2013

CollabRx Inks Distribution Partnership with Projects In Knowledge
Premium

Mar 7, 2013

CollabRx Inks Distribution Deal with Projects In Knowledge

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.